BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 30253874)

  • 21. Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival in Patients Treated With Lung Stereotactic Body Radiation Therapy (SBRT).
    Glick D; Lyen S; Kandel S; Shapera S; Le LW; Lindsay P; Wong O; Bezjak A; Brade A; Cho BCJ; Hope A; Sun A; Giuliani M
    Clin Lung Cancer; 2018 Mar; 19(2):e219-e226. PubMed ID: 29066051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extent and computed tomography appearance of early radiation induced lung injury for non-small cell lung cancer.
    Bernchou U; Christiansen RL; Asmussen JT; Schytte T; Hansen O; Brink C
    Radiother Oncol; 2017 Apr; 123(1):93-98. PubMed ID: 28259449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation injury of the lung after stereotactic body radiation therapy (SBRT) for lung cancer: a timeline and pattern of CT changes.
    Linda A; Trovo M; Bradley JD
    Eur J Radiol; 2011 Jul; 79(1):147-54. PubMed ID: 19954913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary injury and tumor response after stereotactic body radiotherapy (SBRT): results of a serial follow-up CT study.
    Guckenberger M; Heilman K; Wulf J; Mueller G; Beckmann G; Flentje M
    Radiother Oncol; 2007 Dec; 85(3):435-42. PubMed ID: 18053602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity.
    Ong CL; Palma D; Verbakel WF; Slotman BJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):431-6. PubMed ID: 20971523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT.
    Ogawa Y; Shibamoto Y; Hashizume C; Kondo T; Iwata H; Tomita N; Ogino H
    Radiat Oncol; 2018 Jul; 13(1):136. PubMed ID: 30055636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment and agreement of the CT appearance pattern and its severity grading of radiation-induced lung injury after stereotactic body radiotherapy for lung cancer.
    Yamamoto T; Kadoya N; Morishita Y; Sato Y; Matsushita H; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Jingu K
    PLoS One; 2018; 13(10):e0204734. PubMed ID: 30286105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits.
    Song DY; Benedict SH; Cardinale RM; Chung TD; Chang MG; Schmidt-Ullrich RK
    Am J Clin Oncol; 2005 Dec; 28(6):591-6. PubMed ID: 16317270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the relationship between the range of radiation-induced lung injury on CT images after IMRT for stage I lung cancer and dosimetric parameters.
    Itonaga T; Sugahara S; Mikami R; Saito T; Yamada T; Kurooka M; Shiraishi S; Okubo M; Saito K
    Ann Med; 2021 Dec; 53(1):267-273. PubMed ID: 33430616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
    Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions.
    Bousabarah K; Blanck O; Temming S; Wilhelm ML; Hoevels M; Baus WW; Ruess D; Visser-Vandewalle V; Ruge MI; Treuer H; Kocher M
    Radiat Oncol; 2021 Apr; 16(1):74. PubMed ID: 33863358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
    Pettersson N; Nyman J; Johansson KA
    Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiological and clinical pneumonitis after stereotactic lung radiotherapy: a matched analysis of three-dimensional conformal and volumetric-modulated arc therapy techniques.
    Palma DA; Senan S; Haasbeek CJ; Verbakel WF; Vincent A; Lagerwaard F
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):506-13. PubMed ID: 20584582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
    Ren C; Ji T; Liu T; Dang J; Li G
    Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
    Takeda A; Kunieda E; Ohashi T; Aoki Y; Oku Y; Enomoto T; Nomura K; Sugiura M
    Chest; 2012 Apr; 141(4):858-866. PubMed ID: 21885726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emphysema quantification on computed tomography and its value in predicting radiation pneumonitis in lung cancer treated by stereotactic body radiotherapy.
    Ye L; Zhang Y; Li T; Zhang X; Shi S; Zhao Q; Zeng Z; He J
    J Radiat Res; 2019 May; 60(3):371-379. PubMed ID: 30968939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased Risk of Radiation Pneumonitis With Coincident Concurrent Use of Angiotensin-converting Enzyme Inhibitors in Patients Receiving Lung Stereotactic Body Radiation Therapy.
    Alite F; Balasubramanian N; Adams W; Surucu M; Mescioglu I; Harkenrider MM
    Am J Clin Oncol; 2018 Jun; 41(6):576-580. PubMed ID: 27560156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.